EBF1 and B-cell chronic lymphocytic leukemia: Interestingly, genes that in CLL lost EBF1 binding at their enhancers could be clustered into the functional groups of immune response and cell activation, two pathways of central relevance in the pathophysiology of CLL (Appendix Fig S8E).